Next Article in Journal
Comparing World Health Organization/International Society of Urological Pathology Grading and Fuhrman Grading with the Prognostic Value of Nuclear Area in Patients with Renal Cell Carcinoma
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Welcome to Uro: A New Open Access Platform for Clinical and Experimental Research and Developments in All Fields of Urology and Andrology

Department of Urology, Santa Chiara Regional and Teaching Hospital, 38123 Trento, Italy
Submission received: 1 October 2020 / Accepted: 5 October 2020 / Published: 10 October 2020
Dear esteemed researchers and colleagues,
It is a great pleasure for me to announce a new journal in the field of urology: Uro, published by the MDPI group.
Staying up to date is a necessity in the era of rapid technical innovation, as novel concepts are being constantly introduced into clinical practice from bench research. It is important to stay competitive and to offer patients the best and most innovative clinical approaches.
At the same time, all physicians are required to keep in mind the concept of patient-centered medicine.
We are, therefore, moving between the impressive acceleration of technical and pharmaceutical innovations and the patients’ desire for a tailored approach and personalized medicine.
On the basis of these considerations, an easily accessible source of information is urgently required. From this perspective, Uro makes its first appearance in the world of urological and andrological journals. With great enthusiasm, the Uro editorial board is currently forming to take care of the real needs of researchers and clinically based physicians. We are working with the aim of giving readers a new, easily accessible journal that provides information on the real necessities of everyday clinical practice. In the coming months, a new modality of keeping up to date will be available in Uro.
Keep up to date or perish! That’s our motto!
Uro is taking its first steps, keeping in mind that translational medicine is the bridge between the pre-clinical “world” and everyday clinical practice. The final “core” aspect of Uro is the multidisciplinary approach to “border diseases”. Gynecologists, endocrinologists, surgeons, and infectious diseases specialists are some of the most common physicians involved in the management of urological patients. The multidisciplinary approach is a key component in everyday clinical practice and, moreover, in the improvement of our knowledge. In line with this aim, and to fully cover any aspect of the modern multidisciplinary approach to urological and andrological diseases, a large group of experts from many different backgrounds is enrolling for the Uro mission. Together and with the pivotal help of authors and reviewers, we aim to make the Uro a high-quality and easily accessible tool for all physicians and researchers involved in the management of patients affected by urological diseases. We hope that you will consider Uro as your privileged partner in everyday clinical practice and a source of up-to-date information and news.

Conflicts of Interest

The author declares no conflict of interest.

Share and Cite

MDPI and ACS Style

Cai, T. Welcome to Uro: A New Open Access Platform for Clinical and Experimental Research and Developments in All Fields of Urology and Andrology. Uro 2021, 1, 1. https://doi.org/10.3390/uro1010001

AMA Style

Cai T. Welcome to Uro: A New Open Access Platform for Clinical and Experimental Research and Developments in All Fields of Urology and Andrology. Uro. 2021; 1(1):1. https://doi.org/10.3390/uro1010001

Chicago/Turabian Style

Cai, Tommaso. 2021. "Welcome to Uro: A New Open Access Platform for Clinical and Experimental Research and Developments in All Fields of Urology and Andrology" Uro 1, no. 1: 1. https://doi.org/10.3390/uro1010001

Article Metrics

Back to TopTop